Epitope Allergy Care
Allergy care from home for nasal and eye allergies to pollen, mold, dust mite and pets: a test, a visit with a licensed clinician, and treatment by mail.
The waitlist link opens an email to support@strategixpartners.ai with the subject "Allergy Care waitlist". A sign-up form arrives with launch; until then this site collects nothing.
How it will work
- An at-home allergy blood testCollected at home and sent to a partner laboratory. It covers pollens, molds, dust mite, pets and the major foods.
- A video visit with a licensed clinicianA clinician from a licensed partner network reviews the results with you and decides whether treatment fits.
- Treatment shipped monthlyWhen the clinician prescribes it: under-the-tongue immunotherapy drops, or FDA-approved tablets where they fit, plus other prescriptions when indicated, from a partner pharmacy.
- Check-ins every three monthsSymptom tracking, refills and records in the Epitope app.
What the evidence says about immunotherapy
Under-the-tongue immunotherapy reduced symptoms and medication use for allergic rhinitis across pooled randomized trials.E1Strong1
Allergen immunotherapy prescribed by a specialist is effective in selected people with persistent symptoms.Review2
The FDA-approved allergy tablets carry a boxed warning that they can cause life-threatening allergic reactions, and their labels call for epinephrine to be prescribed.Official text3
Whether immunotherapy fits any one person is the clinician's decision, made with that person.
What it will not include
Oral immunotherapy for food allergy, which needs in-person supervised dosing, and allergy shots. Epitope Allergy Care also will not sell IgG food panels, mycotoxin panels or other tests the evidence does not support.
Pricing
Pricing will be announced at launch.
Who is behind it
Epitope Health is published by Strategix AI Partners LLC. Its clinical standards and evidence library are set by Dr. Jesus Recio, clinical director. Diagnosis and prescribing will be done by licensed clinicians in a partner clinical network, not by Epitope's software and not by Dr. Recio. More about Epitope Health.
Sources
Each source opens on PubMed, DailyMed or the publisher's page. Under each one are the exact words from it that this page relies on, copied word for word and checked against the original.
- Sublingual immunotherapy for allergic rhinitis. Radulovic S, Cochrane Database Syst Rev, 2010. E1Strong Systematic review
The words this page rests on
Overall, we found a significant reduction in symptoms (SMD -0.49; 95% confidence interval (CI) -0.64 to -0.34, P < 0.00001) and medication requirements (SMD -0.32; 95% CI -0.43 to -0.21, P < 0.00001) in participants receiving sublingual immunotherapy compared to placebo.
- Allergic rhinitis. Bousquet J, Nat Rev Dis Primers, 2020. Review Expert review
The words this page rests on
Allergen immunotherapy prescribed by a specialist using high-quality extracts in stratified patients is effective in patients with persistent symptoms.
- ODACTRA (house dust mite allergen extract) sublingual tablet, Prescribing Information. ALK-Abello A/S, 2026. Official text FDA label
The words this page rests on
ODACTRA can cause life-threatening allergic reactions such as anaphylaxis and severe laryngopharyngeal restriction.
Prescribe epinephrine, instruct and train patients or parents/guardians on its appropriate use, and instruct patients or parents/guardians to seek immediate medical care upon its use.